| |
Crude Cancer Prevalence % (95% CI)
| |
|---|
| |
Overall
|
Women
|
Men
|
p-value*
|
|---|
|
N (cancer/No cancer)
|
44/392
|
34/333
|
10/59
| |
|
All thyroid nodules
|
10.1 (7.5–13.3)
|
9.3 (6.3–12.2)
|
14.5 (6.2–22.8)
|
0.186
|
|
Age (years)
|
|
18–29 years
|
16.7 (6.7–26.6)
|
15.2 (4.8–25.6)
|
25.0 (0.0–55.0)
|
0.493
|
|
30–39 years
|
8.8 (3.6–14.0)
|
8.3 (3.1–13.5)
|
16.7 (0.0–46.5)
|
0.482
|
|
40–49 years
|
12.0 (6.5–17.6)
|
11.0 (5.1–16.9)
|
16.7 (1.8–31.6)
|
0.441
|
|
50–59 years
|
5.2 (0.2–10.2)
|
5.0 (0.0–10.5)
|
5.9 (0.0–17.1)
|
0.885
|
|
≥ 60 years
|
8.6 (1.4–15.8)
|
6.8 (0.0–14.3)
|
14.3 (0.0–32.6)
|
0.386
|
|
Ethnicity**
|
|
UAE
|
9.5 (3.6–15.4)
|
7.7 (1.8–13.6)
|
17.6 (0.0–35.8)
|
0.204
|
|
Arabs
|
10.4 (6.5–14.2)
|
10.1 (5.9–14.3)
|
11.6 (2.0–21.2)
|
0.766
|
|
Far-East Asians
|
16.7 (4.5–28.8)
|
12.1 (1.0–23.3)
|
66.7 (13.3–99.9)
|
0.015
|
|
Caucasians
|
15.4 (1.5–29.3)
|
16.0 (1.6–30.4)
|
0
| |
| |
Age-adjusted Cancer Prevalence % (95% CI)
| |
|
All thyroid nodules
|
10.0 (7.7–12.8)
|
9.0 (6.0–11.9)
|
15.1 (6.5–23.8)
|
0.117
|
|
Ethnicitya
|
|
UAE
|
9.6 (3.6–15.6)
|
7.7 (1.8–13.7)
|
18.7 (0.0–37.9)
|
0.166
|
|
Arabs
|
10.0 (6.2–13.8)
|
9.7 (5.5–13.8)
|
10.9 (1.5–20.4)
|
0.799
|
|
Far-East Asians
|
16.8 (4.5–29.0)
|
12.3 (1.0–23.6)
|
65.1 (10.4–99.9)
|
0.019
|
|
Caucasians
|
16.3 (1.7–30.9)
|
17.0 (1.8–32.1)
|
0
| |
- *p-value comparing women vs men
- aNo cancerous nodules in patients of South-East Asians/Other ethnicities
